Cytochrome P-450 CYP2C9 Inducers (weak)
- Name
- Cytochrome P-450 CYP2C9 Inducers (weak)
- Accession Number
- DBCAT003039
- Description
Not Available
- Drugs
Drug Drug Description Delafloxacin A fluoroquinolone antibiotic used to treat skin and skin structure infections. Apalutamide An androgen receptor inhibitor used to treat non-metastatic castration-resistant and metastatic castration-sensitive prostate cancer. Avatrombopag A thrombopoietin receptor agonist used pre-operatively to treat thrombocytopenia in patients with chronic liver disease and in patients with chronic refractory thrombocytopenia. Peginterferon alfa-2b A purified form of human interferon used to stimulate the innate antiviral response in the treatment of hepatitis B and C, genital warts, and some cancers. Warfarin A vitamin K antagonist used to treat venous thromboembolism, pulmonary embolism, thromboembolism with atrial fibrillation, thromboembolism with cardiac valve replacement, and thromboembolic events post myocardial infarction. Ritonavir An HIV protease inhibitor used in combination with other antivirals in the treatment of HIV infection. Isavuconazole Indicated for patients 18 years of age and older for the treatment of invasive aspergillosis [FDA Label]. Indicated for patients 18 years of age and older for the treatment of... Ticagrelor A P2Y12 platelet inhibitor used in patients with a history of myocardial infarction or with acute coronary syndrome (ACS) to prevent future myocardial infarction, stroke and cardiovascular death. - Drugs & Drug Targets